ER+/HER2- Locally Advanced or Metastatic Breast Cancer (ENZENO Study)

Clinical trial NCT04669587 · UNKNOWN

Trial details

NCT number: NCT04669587
Sponsor: EnhancedBio USA Inc.
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Estrogen Receptor-Positive HER2-Negative Locally Advanced Breast Cancer Metastatic Breast Cancer

Start date: 2021-07-26
Primary completion: 2023-01-31
Enrollment: 106

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.